Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 02, 2015 10:22 ET | Source: Clarus Therapeutics, Inc.

Clarus Therapeutics, Inc. Seeks Injunction Against the Marketing of Lipocine, Inc.'s Oral Product for Testosterone Replacement Therapy (LPCN 1021)

NORTHBROOK, Ill., Nov. 2, 2015 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc. today filed a lawsuit against Lipocine, Inc. for infringing a Clarus patent, namely U.S. Patent 8,828,428 ("the '428...
September 18, 2014 14:38 ET | Source: Clarus Therapeutics, Inc.

Clarus Therapeutics Reports FDA Advisory Committees Vote on REXTORO(TM) for Low Testosterone in Men

NORTHBROOK, Ill., Sept. 18, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc. announced today that the U.S. Food and Drug Administration's (FDA) Bone, Reproductive and Urologic Drugs Advisory...
July 21, 2014 08:30 ET | Source: Clarus Therapeutics, Inc.

Clarus Therapeutics Expands Board of Directors With Appointment of Two Pharmaceutical Industry Veterans

NORTHBROOK, Ill., July 21, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO®, an...
June 22, 2014 14:00 ET | Source: Clarus Therapeutics, Inc.

Clarus Therapeutics Presents Phase 3 Data for REXTORO(R) for Men With Hypogonadism

NORTHBROOK, Ill., June 22, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO (...
June 12, 2014 08:30 ET | Source: Clarus Therapeutics, Inc.

Clarus Therapeutics Secures $31.5 Million in Financing

NORTHBROOK, Ill., June 12, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO, an oral...
May 28, 2014 08:30 ET | Source: Clarus Therapeutics, Inc.

Clarus Therapeutics to Present Phase 3 Data for REXTORO(R) at ICE/ENDO 2014

NORTHBROOK, Ill., May 28, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO, an oral...
May 21, 2014 08:30 ET | Source: Clarus Therapeutics, Inc.

Clarus Therapeutics Appoints Patrick Shea Chief Commercial Officer

NORTHBROOK, Ill., May 21, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO, an oral...
March 17, 2014 08:30 ET | Source: Clarus Therapeutics, Inc.

Clarus Therapeutics Appoints John Gargiulo Chief Operating Officer

NORTHBROOK, Ill., March 17, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO, an oral...